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Peripheral mononuclear cell preparations are commonly used as proxies for other tissues
in studies of the role of gene expression and methylation in human disease. Whether
changes in peripheral DNA methylation are associated with changes in peripheral blood or
brain gene expression is not clear. In order to test the former hypothesis and determine
which genome-wide methylation platform was most suitable for our studies of periph-
eral blood cells, we compared the results from two commercially available genome-wide
methylation arrays with respect to genome-wide gene expression using lymphoblast DNA
and RNA from eight individuals at the promoters of 5619 genes.We found that methylation
signatures at these gene promoters were signiﬁcantly correlated with one another across
platforms and with genome-wide gene expression, but the extent of that relationship is
dependent on choice of platform and degree ofmethylation.Taken in contextwith data from
other studies, these data demonstrate that peripheral blood cell methylation is associated
with gene expression and that further studies to clarify the extent of this relationship, and
the relationship between central and peripheral DNA methylation are in order.
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INTRODUCTION
At the nucleic acid level, epigenetic changes are deﬁned as modiﬁ-
cations to DNA that may alter gene expression but do not result in
changes in the primaryDNA sequence. Thesemodiﬁcations can be
transitory, persist for years, or in some instances,may be transgen-
erational (Youngson and Whitelaw, 2008). Epigenetic processes
are key players in neurodevelopment and are hypothesized to
play important roles in many complex behavioral illnesses such
as autism, depression, and substance use (Chahrour and Zoghbi,
2007; Oberlander et al., 2008; Philibert et al., 2010). Consequently,
there is a strong interest among researchers to identify epigenetic
changes associated with disease and illness.
DNA methylation is perhaps the most accessible epigenetic
mechanism (Suzuki and Bird, 2008). DNA methylation results
from the covalent addition of a methyl group to the 5′ carbon on
cytosine. This reaction is catalyzed byDNAmethyltransferases and
typically occurs at CpG dinucleotides residues. Due to selective
evolutionary pressures, CpG dinucleotide pairs are underrepre-
sented throughout the genome, except at discrete regions known
as CpG islands. In general, methylation of regulatory CpG islands
is thought to downregulate transcription by promoting the for-
mation of heterochromatin and preventing the binding of tran-
scription factors (Suzuki and Bird, 2008). However, at least one
large-scale study has failed to demonstrate a signiﬁcant relation-
ship between genome-wide methylation and gene expression (Fan
and Zhang, 2009).
In order to quantify the exact level of DNAmethylation, several
large-scale and two genome-wide methylation assays have been
marketed to aid researchers in identifying genes associated with
biological processes. Each of these technologies exploit unique
biophysical properties of DNA to determine the level of DNA
methylation at large subsets of genomic loci. For example, the
NimbleGen 385K array uses a methylated DNA immunoprecipi-
tation based approach to isolate methylated fragments of genomic
DNA from unmethylated regions. Methylated and unmethylated
segments are then labeled with Cy3 and Cy5 dyes, respectively, and
subjected to competitive hybridization against a set of oligonu-
cleotides representing the promoters of all well characterized Ref-
Seq genes, providing a measure of relative methylation (Roche
NimbleGen, 2007). In contrast, the Illumina HumanMethyla-
tion450 BeadChip, uses bisulﬁte converted DNA and single base
pair extension technology to determine the level of methyla-
tion (Fan et al., 2006). Each of these platforms has been used
extensively.
Like many other groups (Vawter et al., 2004; Glatt et al., 2005;
Nielsen et al., 2008),our group frequently usesmeasures of periph-
eral lymphocyte and lymphoblast gene expression or methylation
as a proxy for expression or methylation in the brain. There-
fore, we have been intensely interested in determining which
methylation platform would work best for our integrated stud-
ies of gene expression and gene methylation. Unfortunately, in
our examination of the literature, we could not ﬁnd independent
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comparisons of the two leading genome-wide platforms or analy-
ses of the relationship between methylation and gene expres-
sion using these platforms. Therefore, in this communication,
we describe our comparison of these two platforms, relating
them to one another, and comparing their utility in predicting
genome-wide RNA expression using DNA and RNA from eight
independent individuals.
MATERIALS AND METHODS
The DNA and RNA used in the studies were derived from bio-
material obtained from eight individuals participating in the Iowa
Adoption Studies (IAS). The IAS uses a case and control adop-
tion approach whose goal is to elucidate the etiology of complex
psychiatric illness. The clinical characteristics of the IAS have
been described elsewhere (Philibert, 2006). All procedures were
approved by the University of Iowa Institutional Review Board.
The DNA and RNA used in this study were prepared, as
previously described, from growth entrained lymphoblast cell
lines (Philibert et al., 2008). Total RNA was prepared from these
cells using Invitrogen RNA puriﬁcation kits (Carlsbad, CA, USA)
according to the instructions of the manufacturer. DNA from
these cells was isolated using cold protein precipitation (Lahiri
and Schnabel, 1993). The quality and integrity of both the DNA
and RNA samples were inspected by spectrophotometer to ensure
integrity.
Genome-wide expression analyses were conducted by the Uni-
versity of IowaDNAFacility using theAffymetrixHumanGenome
U133 2.0 plus Array which contains 29,098 gene speciﬁc oligonu-
cleotide probes following the procedure outlined by the manu-
facturer. The resulting data were then quantile normalized using
Partek Genomic Suite (St. Louis, MO, USA).
Input and methylation enriched fractions of DNA were pre-
pared per the standard NimbleGen protocol (Roche Nimble-
Gen, 2007). Brieﬂy, 20μg of genomic DNA was reduced in
complexity by digestion with MseI, column puriﬁed, with a
small aliquot of the sample being taken for future analysis (i.e.,
input DNA). Five micrograms of the remainder of the digested
DNA from each subject was resuspended in immunoprecipita-
tion buffer (50mM NaPO4, 700mM NaCl, 0.25% Triton X-100)
and hybridized with 1μg of monoclonal mouse anti-5-methyl
cytidine antibody (CalbiochemUSA) at 4˚C overnight. The result-
ing solution was then hybridized to a magnetic bead coupled
secondary antibody (Dynabeads M-280, Invitrogen USA) and
the DNA-antibody moiety puriﬁed by magnetic separation. The
DNA was removed from the antibody complex by overnight
digestion with protease K and column puriﬁed. Then, 100 ng
aliquots of both the methyl enriched DNA fraction and the
input DNA were ampliﬁed using a WGA2 genome ampliﬁca-
tion kit, which selectively ampliﬁes short DNA contigs that are
more amenable to hybridization and was used according to the
manufacturer’s instructions (Sigma, St. Louis). After puriﬁcation,
this DNA was then frozen at −20˚C until use in the microarray
analyses. Hybridization to the NimbleGen 385K RefSeq Whole
Genome Promoter Array was performed under contract by Nim-
bleGen (Madison,WI, USA). M -values were then calculated from
the obtained raw data, quantile normalized, and centered around
zero.
DNA methylation of the samples was also assessed using the
Illumina HumanMethylation450 BeadChip under contract by the
University of Minnesota Genome Center using the protocol spec-
iﬁed by the manufacturer (Illumina, San Diego). The resulting
microarray data were inspected for complete bisulﬁte conversion
of the DNA, and average β-values (i.e., average methylation) for
each CpG residue were determined using the GenomeStudio suite
of software (V2009.2; Methylation module Version 1.5.5., ver-
sion 3.2). The HumanMethylation450 BeadChip contains 485,577
probes that recognize at least 20,216 unique features. Greater
than 99.7% of the 485,577 probes yielded statistically reliable
data. Because DNA methylation values exhibit heteroscedasticity,
to make the data more suitable for statistical analyses, we con-
verted the Illumina β-values to M -values as derived in Du et al.
(2010). This conversion has been shown to appropriate for mid-
range methylation values, but may distort values at methylation
extremes.
RefSeq gene identiﬁcation codes were used to identify genes
common across all three platforms. For the Illumina array data,we
used the manufacturer’s deﬁnition of promoter associated region
as given in the data annotation ﬁles. The NimbleGen array con-
tains probes for promoters of all well characterized RefSeq genes
(Roche NimbleGen, 2011). The promoter regions on these arrays
are covered by 50–75mer probes spaced approximately 100 base
pairs apart. For genes with multiple probes in a particular array,
the average of the presented values was calculated to obtain one
value for each gene. Genes not common to all three platforms
were eliminated. In total, 5619 genes were identiﬁed common to
all platforms.While many of these tiled regions in the NimbleGen
array are non-CpG associated, after eliminating regions not com-
mon to all three platforms, over 93%of the probesmapped toCpG
islands or CpG shores according to the Illumina annotation ﬁle.
Lastly, we z-transformed all values in order to obtain a common
scale with which all arrays could be compared.
Pearson’s linear correlation coefﬁcient and Spearman’s rank-
order correlation coefﬁcients were used to compare the values
from each methylation platform to genome-wide mRNA expres-
sion (Fleiss, 1981). To further elucidate the sources of variance, we
performed an ordinary least squares (OLS) regression, using both
the Illumina and the NimbleGen array to simultaneously predict
gene expression. We then sought to examine the shape and mag-
nitude of the relationship between methylation and expression.
To examine aggregate expression for each percentile of methy-
lation, we separated methylation data into percentile bins and
averaged the expression for every locus within the designated per-
centile and plotted the resulting 100 data points for each array.
Lastly, hierarchical cluster analysis was conducted with CIMmin-
er™(http://discover.nci.gov/cimminer) using thedefault Euclidian
algorithm. All calculations were performed using SPSS version 19
or SAS 9. Figures were plotted using SAS 9 orMicrosoft Excel 2007.
RESULTS
Table 1 shows the clinical and demographic data for the subjects
in this study. In brief, all participants were middle age females of
northern European descent.
Figure 1 describes the overall distribution of the z-transformed
data for each subject for all three platforms. The frequency
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Table 1 | Demographic characteristic of the subjects.
ID Sex Age Ethnicity
Subject 1 Female 55 Caucasian
Subject 2 Female 49 Caucasian
Subject 3 Female 44 Caucasian
Subject 4 Female 46 Caucasian
Subject 5 Female 41 Caucasian
Subject 6 Female 37 Caucasian
Subject 7 Female 40 Caucasian
Subject 8 Female 42 Caucasian
FIGURE 1 |The distribution of z-transformed methylation of gene
expression values (Y -axis) from each platform for each of the subjects
in the study. NimbleGen values are in green, Affymetrix values are in red,
and Illumina values are in blue.
distribution of the NimbleGen and Affymetrix data appears
approximately Gaussian, whereas the Illumina data exhibits a
moderate positive skew which is potentially a source of decreased
correspondence with the other arrays. For comparison, distri-
butions of the raw data are shown in Figure A1 in Appen-
dix. When the data were subjected to hierarchical clustering,
cross-platform variation appeared greater than within platform
variation (Figure A2 in Appendix).
At the level of the individual, the average correlation between
gene methylation and mRNA expression was signiﬁcant and
trended in the directions expected (see Figure 2). In general, there
was a trend toward increasing expression with decreasing methy-
lation for all eight subjects, although considerable variation was
evident across individuals. Pearson’s correlation coefﬁcients were
between−0.131 and−0.024when comparing theAffymetrix array
with the NimbleGen array.When comparing the Affymetrix array
with the Illumina array, Pearson’s correlation coefﬁcients ranged
between −0.094 and −0.069. Pearson’s correlation coefﬁcients
for all analyses are shown in Table 2. In general, the NimbleGen
array showed stronger predictive scores, albeit being less consis-
tent. For these comparisons we used the M -value conversion for
the Illumina array values as recommended by Du et al. (2010).We
FIGURE 2 | Bivariate analytic plots of the relationship between: (A)
Affymetrix gene expression and NimbleGen methylation data
(r 2 =−0.131) (B) Affymetrix gene expression and Illumina methylation
data (r 2 =−0.073) and (C) NimbleGen and Illumina methylation data
(r 2 =0.131).
found similar results for all analyses whetherM -values or β-values
were used. Figure 2 shows the scatterplots for the genome-wide
methylation-expression comparisons for Subject 1. Scatterplots
for the other seven individuals are available upon request.
When we compared the values for each methylation arrays, we
found a slight positive correlation suggesting that they are, in fact,
measuring the same diathesis, albeit to a lesser degree than antici-
pated. Pearson’s correlation coefﬁcients ranged between 0.131 and
0.059 for these comparisons. To examine the differential validity
of the Illumina and NimbleGen arrays in predicting expression
we conducted an OLS analysis, using the values for each array as
predictors of expression. In this OLS regression, we found that
each array accounted for signiﬁcant variance in gene expression,
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Table 2 | Correlation of methylation and gene expression platforms.
PlatformA Platform B ID Pearson’s Spearman’s N
Affymetrix NimbleGen Subject 1 −0.131** −0.143** 5619
Subject 2 −0.120** −0.135** 5619
Subject 3 −0.037** −0.051** 5619
Subject 4 −0.103** −0.117** 5619
Subject 5 −0.040** −0.051** 5619
Subject 6 −0.024 −0.037** 5619
Subject 7 −0.111** −0.122** 5619
Subject 8 −0.105** −0.117** 5619
Average −0.084 −0.097
Affymetrix Illumina Subject 1 −0.073** −0.056** 5619
Subject 2 −0.079** −0.066** 5619
Subject 3 −0.076** −0.066** 5619
Subject 4 −0.073** −0.061** 5619
Subject 5 −0.094** −0.080** 5619
Subject 6 −0.086** −0.075** 5619
Subject 7 −0.069** −0.061** 5619
Subject 8 −0.079** −0.069** 5619
Average −0.077 −0.067
NimbleGen Illumina Subject 1 0.131** 0.118** 5619
Subject 2 0.122** 0.104** 5619
Subject 3 0.059** 0.054** 5619
Subject 4 0.102** 0.090** 5619
Subject 5 0.060** 0.052** 5619
Subject 6 0.067** 0.061** 5619
Subject 7 0.108** 0.095** 5619
Subject 8 0.106** 0.096** 5619
Average 0.094 0.084
*Correlation is signiﬁcant at the 0.05 level (two-tailed).
**Correlation is signiﬁcant at the 0.01 level (two-tailed).
suggesting that each provided valid, unique information in addi-
tion to shared prediction of gene expression (Table 3). In ﬁve of
the eight cases, the NimbleGen arrays were better predictors of
expression.
One recent investigation has suggested that DNA methyla-
tion may not affect transcription in the same manner at all
genes (Park and Nakai, 2011). In order to examine whether cryp-
tic dichotomies may exist within our data, we plotted average
expression as a percentage of methylation for each array based
on z-scores. We found that maximal expression occurred around
the around the 13th–25th percentiles with a monotonic decrease
in expression as percent methylation increased above this range
(Figure 3). The two arrays corresponded moderately well with
each other with a Pearson’s correlation coefﬁcient of 0.232 across
the full range. Interestingly, as Figure 3 shows, with respect to the
Illumina data, expression was suppressed at the lowest extremes
of methylation. Moreover, the lowest percentile methylation val-
ues exhibited the largest discordance between the twomethylation
arrays.Discordancewas alsonoted at theupper extremesofmethy-
lation, but not to the same extent as the lower extremes. When we
examined the middle 80% of methylation percentiles, ignoring
10% on either side of the curve, the correlation increased to 0.626,
suggesting moderate to strong overall predictability between the
two arrays when examining genes that are not in the extreme
portions of the methylation distribution.
DISCUSSION
In summary, we compared the relationship of genome-wide lym-
phoblast DNA methylation at gene promoters to gene expres-
sion utilizing two widely used, commercially available platforms.
Despite ﬁnding weak correlations between gene expression and
DNA methylation within individuals across all queried loci, we
found strong relationships between gene expression and gene
methylation when we examined the average expression for each
percentile methylation, particularly in the modal portion of the
distribution of methylation values.
The current ﬁndings have certain limitations including the
small number of samples examined. In addition, it is important
to note that gene expression and methylation were derived using
material from lymphoblast cell lines. Although these commonly
used models have many strengths, they are not always represen-
tative of their cognate lymphocyte precursors and are subject to
clonal skewing and effects of both the EBV transformation and
cell passaging (Grafodatskaya et al., 2010).
Recently,Bock et al. (2010) compared a prior generation of Illu-
mina array (the HumanMethylation 27K array) with three other
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Table 3 | Ordinary least squares analysis of the relationship of methylation to gene expression.
Model Model r2 β t -Score Significance
SUBJECT 1
NimbleGen 0.0172 −0.124 −9.304 0.000
Illumina 0.0053 −0.057 −4.289 0.000
Constant −0.002 0.998
SUBJECT 2
NimbleGen 0.0144 −0.112 −8.378 0.000
Illumina 0.0062 −0.065 −4.910 0.000
Constant −0.003 0.998
SUBJECT 3
NimbleGen 0.0014 −0.033 −2.463 0.014
Illumina 0.0058 −0.074 −5.547 0.000
Constant −0.003 0.998
SUBJECT 4
NimbleGen 0.0106 −0.097 −7.267 0.000
Illumina 0.0053 0.063 −4.750 0.000
Constant −0.003 0.998
SUBJECT 5
NimbleGen 0.0016 −0.034 −2.582 0.010
Illumina 0.0088 −0.092 −6.945 0.000
Constant 0.003 0.997
SUBJECT 6
NimbleGen 0.0006 −0.019 1.404 0.160
Illumina 0.0074 −0.085 −6.380 0.000
Constant 0.003 0.997
SUBJECT 7
NimbleGen 0.0123 −0.105 −7.903 0.000
Illumina 0.0048 −0.058 −4.327 0.000
Constant −0.002 0.998
SUBJECT 8
NimbleGen 0.0110 0.097 −7.304 0.000
Illumina 0.0062 −0.069 −5.198 0.000
Constant −0.003 0.998
FIGURE 3 |The relationship of gene methylation to gene expression for
the NimbleGen (red line) and the Illumina platform (green line) at each
percentile of the z-score of the gene expression distribution.
DNA methylation sequencing technologies. Their data demon-
strated a high degree of correlation between the results using
the 27K array and the methylated DNA immunoprecipitation
sequencing (MeDip-Seq), methylated DNA captured by afﬁnity
puriﬁcation (Methyl-Cap Seq) and reduced representation bisul-
ﬁte sequencing (RRBS). However, the results of Bock and col-
leagues are not directly comparable to the current results because
they did not include data from any NimbleGen platforms.
Consistent with some, but not all prior studies, both platforms
demonstrated a correlation between increased promoter methy-
lation and genome-wide gene expression (Fan and Zhang, 2009;
Brenet et al., 2011; Pai et al., 2011). However, it is likely that the
current analyses underestimate the extent of the true relationship
between methylation and gene expression. In the current analy-
ses, we aggregated the values for all promoter associated regions.
Although this is an excellent way to begin an unbiased analysis, this
approach ignores the fact that the status of some regions, especially
certain CpG islands, will be found to be more predictive of gene
expression than others. Second, the Affymetrix gene expression
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array that was used in the study is not exon speciﬁc but rather sums
all transcripts from a given gene. Since promoter associated CpG
islands preferentially affect transcripts containing exons in their
immediate vicinity (Brenet et al., 2011) and many genes contain
non-promoter associated CpG islands that also may affect gene
transcription, it is likely that future studies which focus on critical
CpG residues and relevantly spliced transcripts will produce more
robust relationships. Third, 7% of the promoter associated regions
did not overlap CpG islands andmay serve functions distinct from
those of promoter associated CpG islands.
The overall distribution of the expression data in relation to
percentile methylation illustrates several important ﬁndings and
identiﬁes a cautionary note. As expected, expression decreases
monotonically as methylation increases at loci of mid-range
methylation. However, this pattern did not persist at methyla-
tion extremes. At lowmethylation values, we found an unexpected
decrease in expression when using data derived from the Illumina
platform.However, it is important to note that these islands tended
to be smaller and poorly covered in the 450K platform. Another
possibility for this observation may be driven by technical limita-
tion. The Du et al. (2010) derivation, used to convert β-values to
M -values, is less predictive outside of mid-range β-values. Even
after converting the Illumina β-values to M -values, the resulting
data did still exhibit some positive skew. Consequently, few probes
fell into the low percentile z-scores, potentially leading to sample
bias. Interestingly, however,we found nearly identical results when
using the untransformed β-values.
It is possible that the low concordance and discrepant gene
regulation at the low range of gene methylation may be partially
artifactual. The regions in the 1st percentile of the methylation in
the Illumina array data tended to be much smaller and had fewer
(2.8± 2.6) probes per region as compared to those in the 50th
percentile of the distribution (5.9± 3.9; p< 0.0001). In addition,
it is important to note that although the regions were deﬁned
similarly, the NimbleGen and Illumina arrays may target slight
biological diatheses. The area of methylation effectively targeted
by theNimbleGen array includes all the areawithin theMseI digest
cut sites while the Illumina array effectively targets a select set of
CpG sites within a CpG island whose inclusion is not dependent
on the presence or absence of MseI cut sites. Finally, even though
we did not detect any signiﬁcant effect of data transformation, the
Illumina array data were transformed prior to analyses,whichmay
introduce distortions at the extreme ranges of methylation.
In actual laboratory practice, each of the approaches has its
strengths and weaknesses. For example, in this study, the results
using the NimbleGen platform were slightly more robust. How-
ever, it shouldbenoted that this increase in sensitivitywas obtained
at the cost of signiﬁcant amounts of bench work which required
a high degree of technical expertise. At the same time, although
the Illumina based approach was much easier to perform and pro-
vided data of comparable utility for themajority of genes, Illumina
does not offer a genome-wide platform for studies of rodents.
Hence, one is not able to use this approach in comparative stud-
ies of rodents and human genome-wide DNA methylation. In the
future, direct sequencing of the methylome may make both of
these methods obsolete. However, at the current time, genome-
wide sequencing of bisulﬁte converted DNA remains a technique
limited to isolated laboratory groups (Rauch et al., 2009).
These ﬁndings have signiﬁcant implications for behavioral sci-
entists that use lymphocytes or lymphoblasts in their studies. In
general, they indicate that changes in DNA methylation in these
cells are functionally correlated with changes in gene expression at
the vast majority of genes. Because others have shown that overall
gene expression and methylation in these cells is correlated with
brain gene expression and methylation (Fan and Zhang, 2009;
Rollins et al., 2010), these ﬁndings create an additional credence
for the use of these cell models in studies of neuropsychiatric
disorders.
In conclusion, we demonstrate a signiﬁcant genome-wide rela-
tionship between lymphoblast DNAmethylation and gene expres-
sion and report a direct head-to-head comparison of two leading
DNA methylation platforms. We conclude that investigators con-
templating the use of either platform will need to balance the
complexities inherent in performing the MeDip based Nimble-
Gen measurements versus the ease of performing the Illumina
Inﬁnium assays as performed by third party providers.
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APPENDIX
FIGUREA1 | Distribution of raw data.
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FIGUREA2 | A heat map plot of the methylation and gene expression
values for each subject in the study.
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FIGUREA3 |The relationship between gene expression and gene methylation at each percentage point of the standardized distribution of gene
expression data for the NimbleGen and the Illumina platforms.
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